Skip to content

NEXT-CHEMX CORPORATION: 10-Q filed 2024-11-19

What NEXT-CHEMX CORPORATION reported in its quarterly report filed 2024-11-19 (fiscal Q3 2024): 26 published measures, 82 facts as tagged in accession 0001493152-24-046731.

This filing

Form
10-Q (quarterly report)
Filed
2024-11-19
Fiscal period
fiscal Q3 2024
Accession
0001493152-24-046731 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All NEXT-CHEMX CORPORATION filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2024-09-303,853,418USD
At 2023-12-313,303,062USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2024-09-305,702,132USD
At 2023-12-313,932,425USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2024-09-30-1,848,714USD
At 2024-06-30-1,494,239USD
At 2024-03-31-1,148,326USD
At 2023-12-31-629,363USD
At 2023-09-30-46,686USD
At 2023-06-30376,171USD
At 2023-03-31773,895USD
At 2022-12-31731,868USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2024-07-01 to 2024-09-30-354,495USD92
2024-01-01 to 2024-09-30-1,219,391USD274
2024-04-01 to 2024-06-30-345,933USD91
2024-01-01 to 2024-03-31-518,963USD91
2023-07-01 to 2023-09-30-922,857USD92
2023-01-01 to 2023-09-30-1,778,554USD273
2023-04-01 to 2023-06-30-397,724USD91
2023-01-01 to 2023-03-31-457,973USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2024-01-01 to 2024-09-30-1,033,072USD274
2023-01-01 to 2023-09-30-366,458USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2024-01-01 to 2024-09-301,066,000USD274
2023-01-01 to 2023-09-30398,993USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2024-09-30-7,273,354USD
At 2023-12-31-6,053,963USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2024-07-01 to 2024-09-3028,546,834shares92
2024-01-01 to 2024-09-3028,546,834shares274
2023-07-01 to 2023-09-3028,495,747shares92
2023-01-01 to 2023-09-3028,439,508shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2024-07-01 to 2024-09-3028,546,834shares92
2024-01-01 to 2024-09-3028,546,834shares274
2023-07-01 to 2023-09-3028,495,747shares92
2023-01-01 to 2023-09-3028,439,508shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2024-07-01 to 2024-09-30-0.01USD/shares92
2024-01-01 to 2024-09-30-0.04USD/shares274
2023-07-01 to 2023-09-30-0.03USD/shares92
2023-01-01 to 2023-09-30-0.06USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2024-07-01 to 2024-09-30-0.01USD/shares92
2024-01-01 to 2024-09-30-0.04USD/shares274
2023-07-01 to 2023-09-30-0.03USD/shares92
2023-01-01 to 2023-09-30-0.06USD/shares273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2024-09-308,619USD
At 2023-12-3112,621USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2024-07-01 to 2024-09-30-319,441USD92
2024-01-01 to 2024-09-30-1,163,868USD274
2023-07-01 to 2023-09-30-403,435USD92
2023-01-01 to 2023-09-30-1,421,663USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2024-09-30694,685USD
At 2023-12-31140,327USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2024-09-304,482,128USD
At 2023-12-313,932,425USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2024-07-01 to 2024-09-30319,441USD92
2024-01-01 to 2024-09-301,163,868USD274
2023-07-01 to 2023-09-30403,435USD92
2023-01-01 to 2023-09-301,421,663USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2024-09-3028,546,834shares
At 2023-12-3128,546,834shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2024-09-305,396,053USD
At 2023-12-315,396,053USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2024-09-303,150,114USD
At 2023-12-313,150,114USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2024-09-30591,070USD
At 2023-12-3172,925USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2024-07-01 to 2024-09-30319,441USD92
2024-01-01 to 2024-09-301,163,868USD274
2023-07-01 to 2023-09-30403,435USD92
2023-01-01 to 2023-09-301,421,663USD273

Nonoperating interest expense

Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.

PeriodValueUnitDays
2024-07-01 to 2024-09-3049,455USD92
2024-01-01 to 2024-09-30128,351USD274
2023-07-01 to 2023-09-3019,422USD92
2023-01-01 to 2023-09-3059,944USD273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2024-07-01 to 2024-09-3014,401USD92
2024-01-01 to 2024-09-3072,828USD274
2023-07-01 to 2023-09-30-500,000USD92
2023-01-01 to 2023-09-30-296,947USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2024-07-01 to 2024-09-30-35,054USD92
2024-01-01 to 2024-09-30-55,523USD274
2023-07-01 to 2023-09-30-519,422USD92
2023-01-01 to 2023-09-30-356,891USD273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2023-01-01 to 2023-09-3037,212USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2023-01-01 to 2023-09-30500,000USD273

Inspect the source

Entity
NEXT-CHEMX CORPORATION / CIK 0001657045
Captured
2026-09-21T17:22:10.634Z
SEC response SHA-256
8b9a80f4ed1ebf8fe92d09d5bdb4d230a70a76b781701efdf934f25953154fca

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001657045.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))